Abrdn PLC Bio Rad Laboratories, Inc. Transaction History

Abrdn PLC

$51 Billion
Q2 2024

A detailed history of Abrdn PLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Abrdn PLC holds 8,233 shares of BIO stock, worth $2.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,233

Previous 8,663 4.96%

Holding current value

$2.73 Million

Previous $3 Million 24.97%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$268.26 - $339.48 $115,351 - $145,976	-430 Reduced 4.96%	8,233 $2.25 Million
Q1 2024 May 08, 2024	SELL	$304.11 - $351.99 $39,230 - $45,406	-129 Reduced 1.47%	8,663 $3 Million
Q4 2023 Jan 31, 2024	BUY	$269.37 - $365.04 $966,499 - $1.31 Million	3,588 Added 68.95%	8,792 $2.84 Million
Q3 2023 Nov 06, 2023	SELL	$350.25 - $422.63 $91,415 - $110,306	-261 Reduced 4.78%	5,204 $1.87 Million
Q2 2023 Jun 20, 2024	SELL	$359.49 - $486.4 $84,120 - $113,817	-234 Reduced 4.11%	5,465 $2.07 Million
Q2 2023 Aug 04, 2023	SELL	$359.49 - $486.4 $84,120 - $113,817	-234 Reduced 4.11%	5,465 $2.07 Million
Q1 2023 Jun 20, 2024	SELL	$418.69 - $503.0 $1.07 Million - $1.29 Million	-2,566 Reduced 31.05%	5,699 $2.73 Million
Q1 2023 Apr 28, 2023	SELL	$418.69 - $503.0 $1.07 Million - $1.29 Million	-2,566 Reduced 31.05%	5,699 $2.73 Million
Q4 2022 Jun 20, 2024	SELL	$351.71 - $456.01 $139,980 - $181,491	-398 Reduced 4.59%	8,265 $3.48 Million
Q4 2022 Feb 09, 2023	BUY	$351.71 - $456.01 $1.09 Million - $1.41 Million	3,085 Added 59.56%	8,265 $3.48 Million
Q3 2022 Nov 10, 2022	BUY	$412.59 - $563.26 $12,790 - $17,461	31 Added 0.6%	5,180 $2.16 Million
Q2 2022 Aug 05, 2022	SELL	$463.67 - $597.16 $86,242 - $111,071	-186 Reduced 3.49%	5,149 $2.56 Million
Q1 2022 May 04, 2022	SELL	$524.57 - $735.42 $521,947 - $731,742	-995 Reduced 15.72%	5,335 $3.06 Million
Q4 2021 Feb 08, 2022	SELL	$708.84 - $794.68 $527,376 - $591,241	-744 Reduced 10.52%	6,330 $4.78 Million
Q3 2021 Nov 15, 2021	SELL	$657.71 - $825.77 $1.51 Million - $1.89 Million	-2,293 Reduced 24.48%	7,074 $5.3 Million
Q2 2021 Aug 10, 2021	SELL	$576.64 - $649.04 $103,795 - $116,827	-180 Reduced 1.89%	9,367 $6.04 Million
Q1 2021 May 06, 2021	BUY	$547.01 - $662.35 $177,778 - $215,263	325 Added 3.52%	9,547 $5.45 Million
Q4 2020 Feb 10, 2021	BUY	$510.68 - $643.45 $1.32 Million - $1.66 Million	2,578 Added 38.8%	9,222 $5.38 Million
Q3 2020 Oct 21, 2020	BUY	$454.43 - $535.6 $238,121 - $280,654	524 Added 8.56%	6,644 $3.43 Million
Q2 2020 Aug 10, 2020	BUY	$334.87 - $493.06 $1.61 Million - $2.37 Million	4,809 Added 366.82%	6,120 $2.76 Million
Q1 2020 May 13, 2020	BUY	$320.01 - $409.07 $54,721 - $69,950	171 Added 15.0%	1,311 $460,000
Q4 2019 Feb 18, 2020	BUY	$319.73 - $374.2 $364,492 - $426,588	1,140 New	1,140 $422,000

Others Institutions Holding BIO

# of Institutions

461

Shares Held

19.6M

Call Options Held

23.2K

Put Options Held

37.4K

View Full List

About BIO-RAD LABORATORIES, INC.

Ticker BIO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,633,900
Market Cap $8.17B
Description
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...

More about BIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abrdn PLC, based on Form 13F filings with the SEC.

News

Stay updated on Abrdn PLC with notifications on news.

Account